Skip to content

Clinical trials

Phase 4 Obesity trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 4 Country / region: United Kingdom Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20111
20131
20171
20181
20211
20221
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status3
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Nottingham2
University of Surrey2
Cambridge University Hospitals NHS Foundation Trust1
Eli Lilly and Company1
Novo Nordisk A/S1
Sandwell & West Birmingham Hospitals NHS Trust1
St Andrew's Healthcare1
The Cleveland Clinic1
University College, London1
University of Leicester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity12
Diabetes Mellitus, Type 24
Diabetes Mellitus2
Diabesity1
Insulin Resistance1
Liver Cirrhosis1
Mental Disorders1
Non-alcoholic Fatty Liver Disease1
Overweight1
Weight Loss1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.